Skip to content
Research Article Open access CC BY 4.0

Microbiome-Driven Regulation of Brain Function: Molecular Pathways Linking Gut and Neuropsychiatric Health

Rajesh Ramasandra Venkataraja, Pramod Kumar Meghwal, Brendon Lalchawimawia

Journal of Advances in Biology & Biotechnology · pp. 231–244 · Published 6 Feb 2026

10.9734/jabb/2026/v29i23631

Abstract

This review critically appraises seminal studies on emerging mechanisms of gut-brain communication, summarising microbiome-targeted clinical interventions, and highlighting future trajectories for therapeutic development in mental health. The gut microbiome, comprising trillions of microbial cells, exerts major influence over host metabolism, immunity, and neural function. Through the gut–brain axis, a complex network linking neural, immune, and endocrine pathways, microbial communities shape cognition and emotional regulation. Mounting evidence identifies key microbial taxa, metabolites, and molecular pathways governing mental health. Core mediators include short-chain fatty acids, tryptophan–kynurenine metabolites, and bile acid derivatives, which modulate blood–brain barrier integrity, neurotransmission, and systemic inflammation. Dysbiosis-driven endotoxaemia, particularly via lipopolysaccharide signalling, activates neuroinflammatory cascades implicated in depression and anxiety. Precision psychobiotics such as Bifidobacterium longum NCC3001 and Lactobacillus plantarum PS128 show strain-specific efficacy in reducing depressive symptoms in randomised controlled trials. Both animal and human studies highlight bidirectional interplay: psychological stress reshapes gut ecology, while microbial imbalance disrupts mood and cognition. Emerging interventions, including faecal microbiota transplantation and synthetic microbial consortia, show translational promise but remain constrained by ethical and regulatory barriers. This review integrates findings from clinical trials, multi-omics mapping, and computational models to clarify microbiome–brain mechanisms. It outlines prospective directions in psychobiotic design, metabolite biomarkers, and systems-based therapeutics, framing the gut microbiome as a modifiable determinant of neuropsychiatric health. With continued rigorous investigation and integration across disciplines, microbiome research is poised to revolutionise our understanding and management of mental health disorders, ultimately enhancing patient outcomes and quality of life.

Gut–brain axis gut microbiota intestinal dysbiosis neuroinflammation psychobiotics depression autism spectrum disorder microbiome-targeted therapy precision psychiatry

Cited by 2

2 citations reported by external sources — individual citing-article records aren't available to list yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.